Download PDF
Journal of Pediatric Neurology 2018; 16(03): 192-201
DOI: 10.1055/s-0037-1604477
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Autoimmune Encephalitis in Children

Thaís Armangue
1   Neuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
2   Rare Diseases Program, Center for Biomedical Network Research, Madrid, Spain
3   Pediatric Neuroimmunology Unit, Department of Neurology, Sant Joan de Déu Children's Hospital, Universitat de Barcelona, Barcelona, Spain
› Author Affiliations
Further Information

Publication History

02 January 2017

16 June 2017

Publication Date:
01 August 2017 (online)

    Permissions and Reprints

Abstract

The recent demonstration of pathogenic immune mechanisms and autoantibodies in some patients with acute encephalopathy has raised interest in the identification of autoimmunity as a treatable cause of encephalitis. Especially in children, autoimmune encephalitis can be triggered by a preceding viral infection (e.g., anti-N-methyl-D-aspartate receptor encephalitis post-herpes simplex encephalitis) or by some acquired or genetic disorders that predispose to brain autoimmunity (e.g., hematopoietic cell transplant, CLTA4 deficiency). This review discusses recent advances in pediatric autoimmune encephalitis, including new insights into immune mechanisms and biomarkers in disorders proven or suspected to be autoimmune.

Keywords

autoimmune encephalitis - herpes simplex encephalitis - antibodies

Funding

This work was supported in part by Instituto Carlos III, Madrid, Spain (CM14/00081 and CV15/00021); Dodot Procter & Gamble research grant sponsored by Asociación Española de Pediatría (AEP, DN040579); Fundación Mutua Madrileña; and Fundació Marató TV3 (20141830).


 

  • References

  • 1 Venkatesan A, Tunkel AR, Bloch KC. , et al; International Encephalitis Consortium. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 2013; 57 (08) 1114-1128
    CrossrefPubMedGoogle Scholar
  • 2 Lancaster E, Dalmau J. Neuronal autoantigens--pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012; 8 (07) 380-390
    CrossrefPubMedGoogle Scholar
  • 3 Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci 2015; 1338: 94-114
    CrossrefPubMedGoogle Scholar
  • 4 Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Verhulst SJ. CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity. Mov Disord 2004; 19 (07) 770-777
    CrossrefPubMedGoogle Scholar
  • 5 Armangue T, Yeshokumar AK, Sepúlveda M, Graus F, Saiz A. , et al. Antibodies in acquired demyelinating disorders in children. Mult Scler Demyelinating Disord 2016; 1: 5
    CrossrefPubMedGoogle Scholar
  • 6 Krupp LB, Tardieu M, Amato MP. , et al; International Pediatric Multiple Sclerosis Study Group. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013; 19 (10) 1261-1267
    CrossrefPubMedGoogle Scholar
  • 7 Kramer U, Chi CS, Lin KL. , et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia 2011; 52 (11) 1956-1965
    CrossrefPubMedGoogle Scholar
  • 8 Bien CG, Granata T, Antozzi C. , et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 2005; 128 (Pt 3): 454-471
    CrossrefPubMedGoogle Scholar
  • 9 Barclay SF, Rand CM, Borch LA. , et al. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD): exome sequencing of trios, monozygotic twins and tumours. Orphanet J Rare Dis 2015; 10: 103
    CrossrefPubMedGoogle Scholar
  • 10 Armangue T, Leypoldt F, Málaga I. , et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 2014; 75 (02) 317-323
    CrossrefPubMedGoogle Scholar
  • 11 Singh RR, Sedani S, Lim M, Wassmer E, Absoud M. RANBP2 mutation and acute necrotizing encephalopathy: 2 cases and a literature review of the expanding clinico-radiological phenotype. Eur J Paediatr Neurol 2015; 19 (02) 106-113
    CrossrefPubMedGoogle Scholar
  • 12 Raspall-Chaure M, Armangué T, Elorza I, Sanchez-Montanez A, Vicente-Rasoamalala M, Macaya A. Epileptic encephalopathy after HHV6 post-transplant acute limbic encephalitis in children: confirmation of a new epilepsy syndrome. Epilepsy Res 2013; 105 (03) 419-422
    CrossrefPubMedGoogle Scholar
  • 13 Crow YJ. Type I interferonopathies: mendelian type I interferon up-regulation. Curr Opin Immunol 2015; 32: 7-12
    CrossrefPubMedGoogle Scholar
  • 14 Schubert D, Bode C, Kenefeck R. , et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med 2014; 20 (12) 1410-1416
    CrossrefPubMedGoogle Scholar
  • 15 Carneiro-Sampaio M, Coutinho A. Early-onset autoimmune disease as a manifestation of primary immunodeficiency. Front Immunol 2015; 6: 185
    PubMedGoogle Scholar
  • 16 Dalmau J, Gleichman AJ, Hughes EG. , et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7 (12) 1091-1098
    CrossrefPubMedGoogle Scholar
  • 17 Gable MS, Gavali S, Radner A. , et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009; 28 (12) 1421-1429
    CrossrefPubMedGoogle Scholar
  • 18 Titulaer MJ, McCracken L, Gabilondo I. , et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12 (02) 157-165
    CrossrefPubMedGoogle Scholar
  • 19 Armangue T, Titulaer MJ, Málaga I. , et al; Spanish Anti-N-methyl-D-Aspartate Receptor (NMDAR) Encephalitis Work Group. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr 2013; 162 (04) 850-856.e2
    CrossrefPubMedGoogle Scholar
  • 20 Pillai SC, Hacohen Y, Tantsis E. , et al. Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome. Pediatrics 2015; 135 (04) e974-e984
    CrossrefPubMedGoogle Scholar
  • 21 Armangue T, Moris G, Cantarín-Extremera V. , et al; Spanish Prospective Multicentric Study of Autoimmunity in Herpes Simplex Encephalitis. Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology 2015; 85 (20) 1736-1743
    CrossrefPubMedGoogle Scholar
  • 22 Elbers JM, Bitnun A, Richardson SE. , et al. A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease?. Pediatrics 2007; 119 (02) e399-e407
    CrossrefPubMedGoogle Scholar
  • 23 Sili U, Kaya A, Mert A. ; HSV Encephalitis Study Group. Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients. J Clin Virol 2014; 60 (02) 112-118
    CrossrefPubMedGoogle Scholar
  • 24 Pranzatelli MR, Travelstead AL, Tate ED. , et al. B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 2004; 62 (09) 1526-1532
    CrossrefPubMedGoogle Scholar
  • 25 Armangue T, Leypoldt F, Dalmau J. Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol 2014; 27 (03) 361-368
    CrossrefPubMedGoogle Scholar
  • 26 Molero-Luis M, Fernández-Ureña S, Jordán I. , et al; Neopterin Working Group. Cerebrospinal fluid neopterin analysis in neuropediatric patients: establishment of a new cut off-value for the identification of inflammatory-immune mediated processes. PLoS One 2013; 8 (12) e83237
    CrossrefPubMedGoogle Scholar
  • 27 Mygland A, Ljøstad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. ; European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010; 17 (01) 8-16 ; e1–e4
    CrossrefPubMedGoogle Scholar
  • 28 Ward KN, Leong HN, Thiruchelvam AD, Atkinson CE, Clark DA. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol 2007; 45 (04) 1298-1304
    CrossrefPubMedGoogle Scholar
  • 29 Granata T, Gobbi G, Spreafico R. , et al. Rasmussen's encephalitis: early characteristics allow diagnosis. Neurology 2003; 60 (03) 422-425
    CrossrefPubMedGoogle Scholar
  • 30 Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012; 79 (11) 1094-1100
    CrossrefPubMedGoogle Scholar
  • 31 Graus F, Titulaer MJ, Balu R. , et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016; 15 (04) 391-404
    CrossrefPubMedGoogle Scholar
  • 32 Handique SK, Das RR, Barman K. , et al. Temporal lobe involvement in Japanese encephalitis: problems in differential diagnosis. AJNR Am J Neuroradiol 2006; 27 (05) 1027-1031
    PubMedGoogle Scholar
  • 33 Chen F, Li J, Liu T, Wang L, Li Y. MRI characteristics of brainstem encephalitis in hand-foot-mouth disease induced by enterovirus type 71--will different MRI manifestations be helpful for prognosis?. Eur J Paediatr Neurol 2013; 17 (05) 486-491
    CrossrefPubMedGoogle Scholar
  • 34 Aliabadi N, Messacar K, Pastula DM. , et al. Enterovirus D68 infection in children with acute flaccid myelitis, Colorado, USA, 2014. Emerg Infect Dis 2016; 22 (08) 1387-1394
    CrossrefPubMedGoogle Scholar
  • 35 Amarnath C, Helen Mary T, Periakarupan A, Gopinathan K, Philson J. Neonatal parechovirus leucoencephalitis- radiological pattern mimicking hypoxic-ischemic encephalopathy. Eur J Radiol 2016; 85 (02) 428-434
    CrossrefPubMedGoogle Scholar
  • 36 Babi MA, Raleigh T, Shapiro RE, McSherry J, Applebee A. MRI and encephalography in fatal eastern equine encephalitis. Neurology 2014; 83 (16) 1483-1483
    CrossrefPubMedGoogle Scholar
  • 37 DiMauro S, Hirano M. MELAS. In: Pagon RA, Adam MP, Ardinger HH. , et al. eds. GeneReviews. Seattle: University of Washington, Seattle; 1993. –2016. Accessed November 29, 2016
    Google Scholar
  • 38 Titulaer MJ, Höftberger R, Iizuka T. , et al. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014; 75 (03) 411-428
    CrossrefPubMedGoogle Scholar
  • 39 Gresa-Arribas N, Titulaer MJ, Torrents A. , et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014; 13 (02) 167-177
    CrossrefPubMedGoogle Scholar
  • 40 Armangue T, Santamaria J, Dalmau J. When a serum test overrides the clinical assessment. Neurology 2015; 84 (13) 1379-1381
    CrossrefPubMedGoogle Scholar
  • 41 Höftberger R, Sepulveda M, Armangue T. , et al. Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler 2015; 21 (07) 866-874
    CrossrefPubMedGoogle Scholar
  • 42 Höftberger R, Titulaer MJ, Sabater L. , et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 2013; 81 (17) 1500-1506
    CrossrefPubMedGoogle Scholar
  • 43 Balint B, Jarius S, Nagel S. , et al. Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology 2014; 82 (17) 1521-1528
    CrossrefPubMedGoogle Scholar
  • 44 Honnorat J, Didelot A, Karantoni E. , et al. Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer. Neurology 2013; 80 (24) 2226-2232
    CrossrefPubMedGoogle Scholar
  • 45 Graus F, Dalmou J, Reñé R. , et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 1997; 15 (08) 2866-2872
    CrossrefPubMedGoogle Scholar
  • 46 Paterson RW, Zandi MS, Armstrong R, Vincent A, Schott JM. Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre. J Neurol Neurosurg Psychiatry 2014; 85 (06) 625-630
    CrossrefPubMedGoogle Scholar
  • 47 Geschwind MD, Tan KM, Lennon VA. , et al. Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol 2008; 65 (10) 1341-1346
    CrossrefPubMedGoogle Scholar
  • 48 Jarius S, Jacobi C, de Seze J. , et al. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler 2011; 17 (09) 1067-1073
    CrossrefPubMedGoogle Scholar
  • 49 Doğan M, Acikgoz E, Acikgoz M, Cesur Y, Ariyuca S, Bektas MS. The frequency of Hashimoto thyroiditis in children and the relationship between urinary iodine level and Hashimoto thyroiditis. J Pediatr Endocrinol Metab 2011; 24 (1–2): 75-80
    PubMedGoogle Scholar
  • 50 Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007; 92 (12) 4575-4582
    CrossrefPubMedGoogle Scholar
  • 51 Petit-Pedrol M, Armangue T, Peng X. , et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 2014; 13 (03) 276-286
    CrossrefPubMedGoogle Scholar
  • 52 Saiz A, Blanco Y, Sabater L. , et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008; 131 (Pt 10): 2553-2563
    CrossrefPubMedGoogle Scholar
  • 53 Granerod J, Cousens S, Davies NW, Crowcroft NS, Thomas SL. New estimates of incidence of encephalitis in England. Emerg Infect Dis 2013; 19 (09) 1455-1462
    CrossrefPubMedGoogle Scholar
  • 54 Florance NR, Davis RL, Lam C. , et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66 (01) 11-18
    CrossrefPubMedGoogle Scholar
  • 55 Sasaki M, Yamada N, Fukumizu M, Sugai K. Basal ganglia lesions in a patient with 3-hydroxyisobutyric aciduria. Brain Dev 2006; 28 (09) 600-603
    CrossrefPubMedGoogle Scholar
  • 56 Planagumà J, Leypoldt F, Mannara F. , et al. Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. Brain 2015; 138 (Pt 1): 94-109
    CrossrefPubMedGoogle Scholar
  • 57 Dalmau J, Tüzün E, Wu HY. , et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61 (01) 25-36
    CrossrefPubMedGoogle Scholar
  • 58 Lebas A, Husson B, Didelot A, Honnorat J, Tardieu M. Expanding spectrum of encephalitis with NMDA receptor antibodies in young children. J Child Neurol 2010; 25 (06) 742-745
    CrossrefPubMedGoogle Scholar
  • 59 Titulaer MJ, Soffietti R, Dalmau J. , et al; European Federation of Neurological Societies. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol 2011; 18 (01) 19-e3
    CrossrefPubMedGoogle Scholar
  • 60 Dale RC, Brilot F, Duffy LV. , et al. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Neurology 2014; 83 (02) 142-150
    CrossrefPubMedGoogle Scholar
  • 61 Prüss H, Finke C, Höltje M. , et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 2012; 72 (06) 902-911
    CrossrefPubMedGoogle Scholar
  • 62 De Tiège X, Rozenberg F, Des Portes V. , et al. Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities. Neurology 2003; 61 (02) 241-243
    CrossrefPubMedGoogle Scholar
  • 63 Leypoldt F, Titulaer MJ, Aguilar E. , et al. Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report. Neurology 2013; 81 (18) 1637-1639
    CrossrefPubMedGoogle Scholar
  • 64 Spatola M, Petit-Pedrol M, Simabukuro MM. , et al. Investigations in GABAA receptor antibody-associated encephalitis. Neurology 2017; 88 (11) 1012-1020
    CrossrefPubMedGoogle Scholar
  • 65 Lancaster E, Martinez-Hernandez E, Titulaer MJ. , et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 2011; 77 (18) 1698-1701
    CrossrefPubMedGoogle Scholar
  • 66 Carr I. The Ophelia syndrome: memory loss in Hodgkin's disease. Lancet 1982; 1 (8276): 844-845
    PubMedGoogle Scholar
  • 67 Singer HS, Mascaro-Blanco A, Alvarez K. , et al. Neuronal antibody biomarkers for Sydenham's chorea identify a new group of children with chronic recurrent episodic acute exacerbations of tic and obsessive compulsive symptoms following a streptococcal infection. PLoS One 2015; 10 (03) e0120499
    CrossrefPubMedGoogle Scholar
  • 68 Dale RC, Merheb V, Pillai S. , et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 2012; 135 (Pt 11): 3453-3468
    CrossrefPubMedGoogle Scholar
  • 69 Baumann M, Hennes EM, Schanda K. , et al. Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases. Mult Scler 2016; 22 (14) 1821-1829
    CrossrefPubMedGoogle Scholar
  • 70 Huppke P, Rostasy K, Karenfort M. , et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler 2013; 19 (07) 941-946
    CrossrefPubMedGoogle Scholar
  • 71 Sepúlveda M, Armangué T, Sola-Valls N. , et al. Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus. Neurol Neuroimmunol Neuroinflamm 2016; 3 (03) e225
    CrossrefPubMedGoogle Scholar
  • 72 Wingerchuk DM, Banwell B, Bennett JL. , et al; International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85 (02) 177-189
    CrossrefPubMedGoogle Scholar
  • 73 Polman CH, Reingold SC, Banwell B. , et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69 (02) 292-302
    CrossrefPubMedGoogle Scholar
  • 74 Rostasy K, Mader S, Schanda K. , et al. Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol 2012; 69 (06) 752-756
    CrossrefPubMedGoogle Scholar
  • 75 Hacohen Y, Absoud M, Deiva K. , et al. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children. Neurol Neuroimmunol Neuroinflamm 2015; 2 (02) e81
    CrossrefPubMedGoogle Scholar
  • 76 Mukhin KY, Mameniškienė R, Mironov MB. , et al. Epilepsia partialis continua in tick-borne Russian spring-summer encephalitis. Acta Neurol Scand 2012; 125 (05) 345-352
    CrossrefPubMedGoogle Scholar
  • 77 Atkins MR, Terrell W, Hulette CM. Rasmussen's syndrome: a study of potential viral etiology. Clin Neuropathol 1995; 14 (01) 7-12
    PubMedGoogle Scholar
  • 78 Mastrangelo M, Mariani R, Menichella A. Eponym: Rasmussen syndrome. Eur J Pediatr 2010; 169 (08) 919-924
    CrossrefPubMedGoogle Scholar
  • 79 Bien CG, Tiemeier H, Sassen R. , et al. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins. Epilepsia 2013; 54 (03) 543-550
    CrossrefPubMedGoogle Scholar
  • 80 Lagarde S, Villeneuve N, Trébuchon A. , et al. Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study. Epilepsia 2016; 57 (06) 956-966
    CrossrefPubMedGoogle Scholar
  • 81 van Baalen A, Häusler M, Boor R. , et al. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia 2010; 51 (07) 1323-1328
    CrossrefPubMedGoogle Scholar
  • 82 Baxter P, Clarke A, Cross H. , et al. Idiopathic catastrophic epileptic encephalopathy presenting with acute onset intractable status. Seizure 2003; 12 (06) 379-387
    CrossrefPubMedGoogle Scholar
  • 83 Rivas-Coppola MS, Shah N, Choudhri AF, Morgan R, Wheless JW. Chronological evolution of magnetic resonance imaging findings in children with febrile infection-related epilepsy syndrome. Pediatr Neurol 2016; 55: 22-29
    CrossrefPubMedGoogle Scholar
  • 84 Tate ED, Allison TJ, Pranzatelli MR, Verhulst SJ. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome. J Pediatr Oncol Nurs 2005; 22 (01) 8-19
    CrossrefPubMedGoogle Scholar
  • 85 Krasenbrink I, Fühlhuber V, Juhasz-Boess I. , et al. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS). Neuropediatrics 2007; 38 (03) 114-116
    Article in Thieme ConnectPubMedGoogle Scholar
  • 86 Mitchell WG, Wooten AA, O'Neil SH, Rodriguez JG, Cruz RE, Wittern R. Effect of increased immunosuppression on developmental outcome of opsoclonus myoclonus syndrome (OMS). J Child Neurol 2015; 30 (08) 976-982
    CrossrefPubMedGoogle Scholar
  • 87 Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung NK, Dalmau J. Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol 2003; 53 (03) 347-353
    CrossrefPubMedGoogle Scholar
  • 88 Armangué T, Sabater L, Torres-Vega E. , et al. Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies. JAMA Neurol 2016; 73 (04) 417-424
    CrossrefPubMedGoogle Scholar
  • 89 McKeon A, Martinez-Hernandez E, Lancaster E. , et al. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol 2013; 70 (01) 44-50
    CrossrefPubMedGoogle Scholar
  • 90 Martinez-Hernandez E, Sepulveda M, Rostásy K. , et al. Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis. JAMA Neurol 2015; 72 (02) 187-193
    CrossrefPubMedGoogle Scholar
  • 91 Tate ED, Pranzatelli MR, Verhulst SJ. , et al. Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome. J Child Neurol 2012; 27 (07) 875-884
    CrossrefPubMedGoogle Scholar
  • 92 Armangue T, Titulaer MJ, Sabater L. , et al. A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma. Ann Neurol 2014; 75 (03) 435-441
    CrossrefPubMedGoogle Scholar
  • 93 Reppucci D, Hamilton J, Yeh EA, Katz S, Al-Saleh S, Narang I. ROHHAD syndrome and evolution of sleep disordered breathing. Orphanet J Rare Dis 2016; 11 (01) 106
    CrossrefPubMedGoogle Scholar
  • 94 Bougnères P, Pantalone L, Linglart A, Rothenbühler A, Le Stunff C. Endocrine manifestations of the rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in childhood. J Clin Endocrinol Metab 2008; 93 (10) 3971-3980
    CrossrefPubMedGoogle Scholar
  • 95 Ize-Ludlow D, Gray JA, Sperling MA. , et al. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood. Pediatrics 2007; 120 (01) e179-e188
    Google Scholar
  • 96 Nunn K, Ouvrier R, Sprague T, Arbuckle S, Docker M. Idiopathic hypothalamic dysfunction: a paraneoplastic syndrome?. J Child Neurol 1997; 12 (04) 276-281
    CrossrefPubMedGoogle Scholar
  • 97 Sartori S, Priante E, Pettenazzo A. , et al. Intrathecal synthesis of oligoclonal bands in rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome: new evidence supporting immunological pathogenesis. J Child Neurol 2014; 29 (03) 421-425
    CrossrefPubMedGoogle Scholar
  • 98 Sirvent N, Bérard E, Chastagner P, Feillet F, Wagner K, Sommelet D. Hypothalamic dysfunction associated with neuroblastoma: evidence for a new Paraneoplastic syndrome?. Med Pediatr Oncol 2003; 40 (05) 326-328
    CrossrefPubMedGoogle Scholar
  • 99 Chow C, Fortier MV, Das L. , et al. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome may have a hypothalamus-periaqueductal gray localization. Pediatr Neurol 2015; 52 (05) 521-525
    CrossrefPubMedGoogle Scholar
  • 100 Howell KB, Tiedemann K, Haeusler G. , et al. Symptomatic generalized epilepsy after HHV6 posttransplant acute limbic encephalitis in children. Epilepsia 2012; 53 (07) e122-e126
    CrossrefPubMedGoogle Scholar
  • 101 Bode SF, Ammann S, Al-Herz W. , et al; Inborn Errors Working Party of the EBMT. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. Haematologica 2015; 100 (07) 978-988
    CrossrefPubMedGoogle Scholar
  • 102 Deiva K, Mahlaoui N, Beaudonnet F. , et al. CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis. Neurology 2012; 78 (15) 1150-1156
    CrossrefPubMedGoogle Scholar
  • 103 Bertrand A, Kostine M, Barnetche T, Truchetet M-E, Schaeverbeke T. Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis. BMC Med 2015; 13: 211
    CrossrefPubMedGoogle Scholar
  • 104 Williams TJ, Benavides DR, Patrice KA. , et al. Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer. JAMA Neurol 2016; 73 (08) 928-933
    CrossrefPubMedGoogle Scholar
  • 105 Rice GI, Kasher PR, Forte GM. , et al. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet 2012; 44 (11) 1243-1248
    CrossrefPubMedGoogle Scholar
  • 106 Parker T, Keddie S, Kidd D. , et al. Neurology of the cryopyrin-associated periodic fever syndrome. Eur J Neurol 2016; 23 (07) 1145-1151
    CrossrefPubMedGoogle Scholar